Algernon Pharmaceuticals Inc. C.AGN

Investorshub is a BS website where you can only cheerleader.

[C10H12N2]

Request Deletion Review

Post Date: 03/10/2023 01:00:07 AM

Board: Algernon Pharmaceuticals Inc

Reason: Off-Topic

Removed Message

There’s nothing Wrong With Dialogue Regarding An Otherwise Boring Story…

Thus, IMO your reply further makes my point(s). You’re a shareholder (I assume) who is primarily counting on DMT to save the day. Where you lose me is not acknowledging the fact AGN Neuro is in fact already a “private” company. You’re attempting to say it is not. However, it is and you not having actual AGN Neuro shares in your account to point to is proof positive. As I’ve stated, I see Algernon Pharmaceuticals hard pressed to raise enough capital for a Phase 2 clinical trial. What year do you think they will ever get around to conducting a standalone Phase 2b Chronic Cough clinical trial? You, along with “management” is banking on the DMT angle lifting AGN/PF out of the abyss based on “news” Moreau will continue to spout to no end. News that most likely you as an AGN/PF shareholder is paying for out of the coffers of Algernon Pharmaceuticals flailing finances. You have absolutely no idea if any money raised from the “private” company is/will be spent on PR. The reason being is that AGN Neuro is “private”. They don’t report what money comes in and/or goes out. You only get periodic Rah Rah Rah from your mouthpiece CEO about how well things are going until it’s woefully apparent they’re not. The run up to COVID-19 final data being a pure example of denial of failed data until the bitter end. You have your spin on what you think Moreau thinks. I’ll stick to what I think based on what I’ve seen and continue to see coming out of this Vancouver outfit. What I see is their efforts to keep the shtick going into perpetuity come hell or high water. Algernon Pharmaceuticals could go bust in very short order. Leaving Algernon Neuro standing as a lone private company or it becoming yet another penny stock. The thought of it ever trading on NASDAQ or any company management is involved in is ludicrous. They are penny stock operators to their core. Thus Algernon Pharmaceuticals goes bust and Algernon Neuro becomes your latest penny stock shtick. You’ll get whatever paltry number of shares they’ll put in your account for what you held as AGN/PF shares and the AGN/PF shares will go up in flames as many of the other plays in pennyland by the same group of penny stock operators. We all know who they are here and Cannabix Technologies Inc.

tmc55

The bet of Ifenprodil use for COVID is history but the IPF/CC path remains valid, IMO.
If an investor held BTH from day one without any trading that was their decision to make and responsibility, IMO.
Most should not be down >50% and the future still holds promise, IMO.
That is also the risk taken with a speculative stock and the possible rewards. IMO.

Really?

What’s severely missing from your opinion is the fact you had a CEO (Moreau) and Chief Science Officer (Dr. Mark Williams, PhD, MBA) spouting off to no end of how the COVID-19 angle had a 65% Chance Of Success (verbally and written). It seems as if no one has any desire to admit that fact. There isn’t a casino in the world with any game of chance with odds better than 49%. So you move your money out of a purported 65% Chance Of Success into what type of investment vessel? Bonds...Mutual Funds...Whole Life Insurance? Christopher Moreau continued to double down and triple down on the narrative of first having a 55% Chance of Success with all the “repurposed” drugs in the pipeline - to Ifenprodil having a "65% Chance Of Success" to treat COVID-19. Which equates to a Phase 2b clinical trial proving efficacy. However, it did not and thus no clinical trial was advanced to Phase 3 as Andre Uddin (Ranked: #413 out of 8,363 Wall Street Analysts and #905 out of 31,882 experts) rightfully predicted in his analysis written and published in black and white. There are some who still want to whitewash history as if shareholders did not act on any of the percentage of success claims made by Algernon Pharmaceuticals (management has EXPERTS at their disposal to make sound and trustworthy/truthful decisions on shareholders behalf/best interest) from the outset. Thus, if you follow the stock action from before the COVID-19 data release to the time period thereafter you can easily see where there were colossal losses in stock price that never recovered to this day. You would have had to pull out well before any data readout to get to what tmc55 claims to be a 50% loss. A 50% loss cannot be proven on any reasonable timeline based on what we all knew and when we all knew it.

Lest we forget, the Biopub angle of the whole COVID-19 sh!tshow story. Biopub took front and center as the bullhorn through which Algernon Pharmaceuticals spouted off all of their conjured up statistics on the fly in those Biopub webcasts. We also have good reason to believe Biopub subscribers were receiving private meetings with Christopher Moreau along with having Dr. KSS, who owns Biopub, is in a Conflict Of Interest by also being a member of Algernon’s “Scentificand Medical Advisory Board”. The twists and turns are endless but they all seem to always end at the beginning of a dumpster fire.

McMagyar - “When DMT microdosing through IV is proved to create Neuro plasticity at non hallucinogenic level.”

There’s nothing wrong with having HOPE (Hope Springs Eternal). However, Dr. David Nutt (Advisor to AGN Neuro and longstanding mouthpiece for all things DMT) has stated he thinks there is a 30% Chance Of Success at Phase 1. That’s less than half of the type of over the top claims Christopher Moreau spews when in total control of the narrative. However, give it some time. If there’s a blip of positive news at Phase 1, I wouldn’t be surprised if Moreau jumps right back into his made up mantra of 55% and/or 65% Chance of Success at Phase 2 for DMT. Damn the fact none of this kind of stuff has ever been proven. Just like COVID-19 having been a disease the world had never before seen. Yet, there you had Algernon Pharmaceuticals prancing around like a peacock convincing the market it had the Silver Bullet. To date, 99.99% of all companies around the globe pursuing treatments for COVID-19 have failed in their endeavors, legitimate or otherwise.

Silver Bullet



Thanks for stating my take/opinion(s) about Algernon Pharmaceuticals is “interesting”. I would also add they’re mostly in depth and always brutally honest.